OptraScan and Inspirata automate oncologic pathology
- November 16, 2021
- Steve Rogerson
US firms OptraScan and Inspirata have joined forces to digitise and automate the oncologic pathology workflow.
California-based OptraScan provides end-to-end digital pathology products and Florida firm Inspirata provides digital pathology and cancer informatics. This partnership will allow pathology labs, healthcare networks and hospitals to acquire digital pathology images without any upfront cost and display them within a workflow.
“We are excited to be working with Inspirata to support their mission to digitise and automate the entire oncologic pathology workflow,” said Abhi Gholap, founder of OptraScan. “Our on-demand scanning model will allow pathologists to digitise their slides without any capital cost.”
Inspirata and OptraScan customers can now use native OptraScan image files from within Inspirata’s Dynamyx digital pathology workflow software. Facilitating slide digitisation at an affordable cost, the seamless integration of OptraScan provides cloud-based whole slide imaging systems and flexibility to choose from 15 slides capacity to 480 slides capacity. Users will be equipped for confocal, brightfield, fluorescence and frozen section applications.
“Inspirata is delighted to work with its friends at OptraScan to accelerate global adoption of digital pathology,” said Mark Lloyd, executive vice president at Inspirata. “OptraScan’s status as an approved partner guarantees the seamless integration of its leading whole slide image scanners with Inspirata’s Dynamyx.”
OptraScan’s on-demand end-to-end digital pathology provides effective acquisition of whole slide images, viewing, storing, real-time sharing, reporting, and AI and ML based image analysis.
Inspirata helps patients fighting cancer and their clinicians by bringing disparate data together throughout the entire cancer care journey to drive informed decisions that improve survivorship.